FDA Genetic Array Submissions Guidance Dovetails With NCCLS Effort
This article was originally published in The Gray Sheet
Executive Summary
FDA's guidance on "Pharmacogenetic Tests and Genetic Tests for Heritable Markers," to be issued by year-end, will exclude gene expression arrays, according to the agency